Bio-Rad Laboratories Inc. reported its earnings for the second quarter of 2025, revealing a modest increase in net sales and a stable financial performance. Despite a challenging market environment, ...

Rad Laboratories ( (BIO) ) has provided an announcement. On October 29, 2025, Bio-Rad Laboratories reported its financial results for the third quarter ended September 30, 2025. Despite challenges in ...

Bio-Rad Laboratories Inc. (BIO.B) on Wednesday reported a third-quarter loss of $341.9 million, after reporting a profit in the same period a ...

Bio-Rad Laboratories, Inc. (BIO) is scheduled to announce Q3 earnings results on Wednesday, October 29th, after market close. The consensus EPS Estimate is $1.9 ...

The outlook for full year 2025 remains unchanged at flat to 1% currency-neutral revenue growth, consistent with the Q2 update. Margins guidance is also unchanged. Q3 reported a slight revenue and ...

UNHCR and its partners actively collect and analyze socioeconomic data to inform sustainable responses that enhance protection, inclusion and solutions for forcibly displaced persons. Our efforts are ...

In September 2025, BioWorld recorded 230 clinical trial updates spanning phases I through III, up sharply from 95 in August, 140 in July and just below 254 in June. Among these, 22 phase III trials ...

Investing.com - Guggenheim has raised its price target on Adicet Bio Inc. (NASDAQ:ACET) to $8.00 from $7.00 while maintaining a Buy rating following impressive clinical data from the company’s lupus ...

Lack of incentives and low adoption of metadata standards are limiting AI's potential for bioimage analysis—a community initiative proposes solutions. AI can spot subtle patterns in millions of ...

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the ...

Tensions at Manhattan's immigration courts are reaching a boiling point. Last week, Immigration and Customs Enforcement reinstated the officer who was initially relieved of duties after shoving an ...

PHILADELPHIA, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell ...